TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors

ABSTRACT: Evaluation of the diagnostic performance of PET / CT with 68Ga-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors with comparison with other techniques used in routine clinical practice (octreoscan ; multiphase SPECT / CT, MRI or endoscopy). Therapeutic impact and safety of PET / CT with 68Ga-DOTANOC will also be assessed. Expected results are a confirmation of the superiority of 68Ga-PET DOTANOC versus scintigraphy octreoscan , with a potential impact on the therapeutic management of patients.

DISEASE(S): Neuroendocrine Tumors,Patients With Gastroenteropancreatic Neuroendocrine Tumors,Pancreatic Neoplasms,Stomach Neoplasms,Intestinal Neoplasms

PROVIDER: 2136662 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR